Update on the development of lurasidone as a treatment for patients with acute schizophrenia
Norio Yasui-FurukoriDepartment of Neuropsychiatry, Hirosaki University School of Medicine, Aomori, JapanAbstract: Lurasidone is a novel benzisothiazole antipsychotic drug for the treatment of schizophrenia. Of the antipsychotic drugs, lurasidone has the highest affinity for the 5-hydroxytryptamine (...
Saved in:
Main Author: | Yasui-Furukori N (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2012-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lurasidone for the Treatment of Schizophrenia: Design, Development, and Place in Therapy
by: Miura I, et al.
Published: (2023) -
Lurasidone for the treatment of schizophrenia in adult and paediatric populations
by: Teresa Guilera, et al.
Published: (2023) -
Clinical potential of lurasidone in the management of schizophrenia
by: Samalin L, et al.
Published: (2011) -
Identification of clinical phenotypes in schizophrenia: the role of lurasidone
by: Marco Andrea Riva, et al.
Published: (2021) -
Cost-utility analysis of lurasidone for the first-line treatment of schizophrenia in China
by: Jia Liu, et al.
Published: (2022)